NCT05185232

Brief Summary

Congenital heart defects (CHDs) are a heterogeneous group of rare diseases of varying severity, each diagnosis with its unique set of co-morbidities. In addition to the heterogeneity, perhaps the greatest challenge to conducting comparative effectiveness research in CHD patients are the poor rates of successful transition from pediatric to adult centered cardiology care and high rates of gaps in recommend care for adults with CHD. This study will use PCORnet to examine the effects of gaps in recommended care (cardiology visits) on patient prioritized outcomes for adults with non-complex and complex subtypes of CHD. This system will be established through 14 (12 recruiting) PCORnet affiliated institutions and linkage to the Congenital Heart Initiative registry (https://chi.eurekaplatform.org), the first patient powered registry for adults with CHD. This registry launched in December 2020, and is IRB approved at Children's National Hospital (IRB# Pro00014697). Funded by PCORI, this project will recruit patients at the 12 PCORnet affiliated institutions and will invite them to contribute their health records data and then join the established Congenital Heart Initiative. By enrolling patients and linking their PCORnet (health record) data into an existing adult congenital heart disease (ACHD) specific registry, future interventions to reduce gaps in care based on study findings can be rapidly implemented in real-world settings through the strong partnerships established with key CHD stakeholders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

16 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

January 11, 2022

Status Verified

January 1, 2022

Enrollment Period

1.5 years

First QC Date

December 21, 2021

Last Update Submit

January 7, 2022

Conditions

Keywords

Healthcare TransitionHealthcare UtilizationPatient Reported OutcomesAccess to CareMental HealthPhysical ActivitiesQuality of LifeCOVID-19

Outcome Measures

Primary Outcomes (3)

  • Rates of healthcare use

    The primary outcome will be the number of visits each year to the following clinical settings, which are thought to reflect access to primary care, cardiology care, or specialist care.

    Month 9-31

  • Rates of comorbidities

    The study investigators will determine the prevalence rates of comorbidities which will be assessed using the Elixhauser comorbidity index developed by AHRQ. Investigators will compare these outcomes among the various CHD subtypes and among patients who do or don't have gaps in care. Investigators will adjust for a number of potential confounders and covariates including: patient factors, regional factors and hospital factors.

    Month 9-31

  • Number of Participants with gaps in care

    Gaps in care will be defined as no cardiology subspecialty visit in \>3-5 years for non-complex CHD subtypes and \>1-2 years for complex CHD subtypes.

    Months 9-31

Other Outcomes (4)

  • Measure of Quality of Life (Patient Reported Outcome)

    Month 10-23

  • Assessing Mental Health (Patient Reported Outcome)

    Month 10-23

  • Evaluating Physical health and functioning (Patient Reported Outcome)

    Month 10-23

  • +1 more other outcomes

Study Arms (2)

Patients with complex congenital heart disease

Complex congenital heart disease will be defined by previously published classification including those listed in the American heart association/ American college of cardiology guidelines for the care of adults with congenital heart disease.

Other: Impact of gaps in care/loss to healthcare follow-up

Patients with non-complex congenital heart disease

Non-complex congenital heart disease will be defined by previously published classification including those listed in the American heart association/ American college of cardiology guidelines for the care of adults with congenital heart disease.

Other: Impact of gaps in care/loss to healthcare follow-up

Interventions

There will not be a discrete intervention as part of this study but study investigators will be examining a set of primary and secondary outcomes in patients who have followed recommended cardiac care vs. those who have not.

Patients with complex congenital heart diseasePatients with non-complex congenital heart disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study population will include Adults including Pregnant women

You may qualify if:

  • For Aims 1 \& 2, participants will be deemed eligible to participate if they meet the following criteria:
  • Age greater than or equal to 18 years at the time of initial data query
  • Diagnosis of Congenital Heart Disease with at least one inpatient, outpatient, or emergency room visit within 8 years prior to the time of the initial data query
  • Retrospective data available for 1-3 years prior to initial data query
  • For Aim 3, participants will be deemed eligible to participate if they meet the following criteria:
  • Age greater than or equal to18 years at the time of initial data query
  • Diagnosis of Congenital Heart Disease with at least one inpatient, outpatient, or emergency room visit within 6 years prior to the time of the initial data query
  • Contact Information (email, address, and/or phone number)
  • Email access through internet connected device or smartphone (Android or iOS)
  • Can read/write English well enough to fill out on-line surveys

You may not qualify if:

  • Age \< 18 years
  • No Congenital Heart Disease (as classified by ICD9/10 codes)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

University of California

San Francisco, California, 94118, United States

Location

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Children's National Hospital

Washington D.C., District of Columbia, 20010, United States

Location

University of Miami

Coral Gables, Florida, 33124, United States

Location

University of Florida

Gainesville, Florida, 32611, United States

Location

Nicklaus Children's Hospital

Miami, Florida, 33155, United States

Location

Louisiana Public Health Institute

New Orleans, Louisiana, 70112, United States

Location

Ochsner

New Orleans, Louisiana, 70121, United States

Location

Mount Sinai

New York, New York, 10003, United States

Location

NYU Langone Health

New York, New York, 10016, United States

Location

Columbia Presbyterian

New York, New York, 10034, United States

Location

Weill Cornell Medicine

New York, New York, 10065, United States

Location

Duke Coordinating Center

Durham, North Carolina, 27701, United States

Location

Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States

Location

Nationwide Children's

Columbus, Ohio, 43205, United States

Location

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (8)

  • Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, Hepner SI, Downing JW. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985 Jan;121(1):31-6. doi: 10.1093/oxfordjournals.aje.a113979.

    PMID: 3964990BACKGROUND
  • Agarwal A, Thombley R, Broberg CS, Harris IS, Foster E, Mahadevan VS, John A, Vittinghoff E, Marcus GM, Dudley RA. Age- and Lesion-Related Comorbidity Burden Among US Adults With Congenital Heart Disease: A Population-Based Study. J Am Heart Assoc. 2019 Oct 15;8(20):e013450. doi: 10.1161/JAHA.119.013450. Epub 2019 Oct 2.

    PMID: 31575318BACKGROUND
  • Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010 Sep 28;56(14):1149-57. doi: 10.1016/j.jacc.2010.03.085.

    PMID: 20863956BACKGROUND
  • Webb G, Landzberg MJ, Daniels CJ. Specialized adult congenital heart care saves lives. Circulation. 2014 May 6;129(18):1795-6. doi: 10.1161/CIRCULATIONAHA.114.009049. Epub 2014 Mar 3. No abstract available.

    PMID: 24589850BACKGROUND
  • Jackson JL, Morack J, Harris M, DeSalvo J, Daniels CJ, Chisolm DJ. Racial disparities in clinic follow-up early in life among survivors of congenital heart disease. Congenit Heart Dis. 2019 Mar;14(2):305-310. doi: 10.1111/chd.12732. Epub 2018 Dec 18.

    PMID: 30561880BACKGROUND
  • Broberg C, McLarry J, Mitchell J, Winter C, Doberne J, Woods P, Burchill L, Weiss J. Accuracy of administrative data for detection and categorization of adult congenital heart disease patients from an electronic medical record. Pediatr Cardiol. 2015 Apr;36(4):719-25. doi: 10.1007/s00246-014-1068-2. Epub 2014 Nov 27.

    PMID: 25428778BACKGROUND
  • Oster ME, Riehle-Colarusso T, Simeone RM, Gurvitz M, Kaltman JR, McConnell M, Rosenthal GL, Honein MA. Public health science agenda for congenital heart defects: report from a Centers for Disease Control and Prevention experts meeting. J Am Heart Assoc. 2013 Aug 28;2(5):e000256. doi: 10.1161/JAHA.113.000256. No abstract available.

    PMID: 23985376BACKGROUND
  • Reid GJ, Irvine MJ, McCrindle BW, Sananes R, Ritvo PG, Siu SC, Webb GD. Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics. 2004 Mar;113(3 Pt 1):e197-205. doi: 10.1542/peds.113.3.e197.

    PMID: 14993577BACKGROUND

MeSH Terms

Conditions

Heart Defects, CongenitalPsychological Well-BeingMotor ActivityCOVID-19

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPersonal SatisfactionBehaviorPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Anitha S John, MD, Ph.D

    Children's National Research Institute

    PRINCIPAL INVESTIGATOR
  • Thomas Carton, Ph.D

    Louisiana Public Health Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anitha S John, MD, Ph.D

CONTACT

Adebola Owolabi, BSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director and Principal Investigator, Washington Adult Congenital Heart Program

Study Record Dates

First Submitted

December 21, 2021

First Posted

January 11, 2022

Study Start

April 1, 2022

Primary Completion

October 1, 2023

Study Completion

June 30, 2024

Last Updated

January 11, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Individual Participant data will not be shared with other researchers.

Locations